2020年12月8日，Nature Cancer期刊在线发表了题为Immune-stimulating antibody conjugates elicit robust myeloidactivation and durable antitumor immunity的研究，该研究介绍了一种抗体偶联TLR7/8激动剂的技术 IASC，原理相当于ADC技术。

2022年12月7日 · The wide range of expression and clinical significance of TLR7/TLR8 in different kinds of cancers have been extensively explored. TLR7/TLR8 can be used as novel diagnostic biomarkers, progression and prognostic indicators, and immunotherapeutic targets for …

2023年9月12日 · TLR7/8识别单链核糖核酸（ssRNA），并通过MyD88依赖性途径发出信号。 在天然配体中，富含腺苷和尿苷的寡核苷酸（ORN）能够激活TLR8，而对TLR7没有任何影响，而富含鸟苷的ORN激活TLR7和TLR8依赖性信号传导。

TLRs 7/8 are located in the endosomal compartment and activate a specific signaling pathway in a MyD88-dependant manner. According to their involvement into various autoimmune, inflammatory and malignant diseases, researchers have designed diverse TLRs 7/8 ligands able to boost or block the inherent signal transduction.

TLR7/8 agonists exhibit potent antiviral activity and regulate anti-tumor immune responses. TLR7 agonists have also been used as adjuvants to improve vaccine immunogenicity and generate greater seroprotection. TLR7/8 antagonists are promising candidates for the treatment of autoimmune and inflammatory diseases.

2021年6月9日 · 基于结构的新型骨架的 TLR7/8 双激动剂的设计 在体外，化合物 24e 和 25a 在人外周血单核细胞试验中显著诱导了细胞因子IFN-α、IFN-γ、TNF-α、IL-1β、IL-12p40和IP-10分泌。

2022年12月7日 · TLR7/TLR8 can be used as novel diagnostic biomarkers, progression and prognostic indicators, and immunotherapeutic targets for various tumors. Although the mechanism of action of TLR7/8 in cancer immunotherapy is still incomplete, TLRs on T cells are involved in the regulation of T cell function and serve as co-stimulatory molecules and ...

2020年2月21日 · TLR7 and TLR8 are pattern recognition receptors that reside in the endosome and are activated by ssRNA molecules. TLR7 and TLR8 are normally part of the antiviral defense response, but they have also been implicated as drivers of autoimmune diseases such as lupus.

2021年8月1日 · In addition to inducing an antiviral state through secretion of type I interferons (IFNs), synthetic TLR7/8 agonists trigger acute inflammation and stimulate adaptive immunity by activating the nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) pathway [12].

2022年12月7日 · TLR 激动剂可以通过先天性和适应性免疫反应激活 T 细胞介导的抗肿瘤反应，从而改善肿瘤治疗。 最近，已经开发出具有不同支架的TLR7或TLR8激动剂的新药物。 这些激动剂导致某些细胞因子和趋化因子的诱导，可应用于某些疾病的治疗，并可用作疫苗的良好佐剂。